Dyspnea
1
Pipeline Programs
5
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
City TherapeuticsMA - Cambridge
1 programNTproBNP measurement with point of care device "Cobash232" in the POCT groupN/A
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstraZenecaCaffeine
RocheTreatment as per model probability
Clinical Trials (2)
Total enrollment: 212 patients across 2 trials
Trial of Caffeine to Alleviate Dyspnea Related to Ticagrelor
Start: Dec 201426 patients
Phase 2Terminated
Impact of Validated Diagnostic Prediction Model of Acute Heart Failure in the Emergency Department
Start: Sep 2010Est. completion: Jun 2014186 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.